The Securities and Exchange Commission (SEC) is reviewing how financial companies market principal protected notes (PPNs), according to Bloomberg news. The SEC’s inquiry is focused on how companies describe the products’ risks and whether the term “principal protected” is misleading and implies that the investment is guaranteed not to fall in value.
UBS had sold more than $1 billion of PPNs, described as safe investments backed by Lehman Brothers that were “guaranteed” against loss of principal. Au contraire, following Lehman Brothers' bankruptcy filing on September 15, 2008, the PPNs are now in default causing the holders of these PPNs to become senior unsecured creditors in the Lehman bankruptcy proceeding. Practically speaking, these investors are left with virtually worthless investments.
One of the big issues concerning Lehman’s collapse—and UBS’ role in selling toxic securities to its clients—concerns what UBS knew about Lehman’s spiraling out of control and when it knew it.
Beginning in the summer of 2007, the cost of insuring short-term obligations (a/k/a, credit default swaps) for Bear Stearns and Lehman Brothers began to increase steadily. The rise reflected the growing concern over solvency of such companies, particularly on the part of those entities who traded with them or loaned them money. Lehman in particular was highly leveraged, owing an inordinate amount of money to third parties and collateralizing it with mortgage-related assets. In fact, Lehman was one of the largest underwriters of mortgage-backed securities in 2007.
On December 4, 2009, the Wall Street Journal reported that a FINRA Arbitration Panel awarded an investor $200,000.00 against because the broker inappropriately sold her risky Lehman Brothers principal protected notes.
The securities law firms Blum & Silver, LLP (www.stockattorneys.com) and Sallah & Cox, LLC (http://www.sallahcox.com) are representing investors in FINRA arbitration claims who suffered losses at UBS as a result of losses in Lehman principal protected notes and Lehman preferred shares. These securities were typically recommended as safe investments. However, many investors allege they were not warned of the risk and suffered extraordinary losses as a result.
For a long time, structured products were sold by European brokerage houses to primarily sophisticated investors, typically institutions. Because of their organization, intricate “structure” - no pun intended - and multiple moving parts, they were often considered too complex for typical individual, retail investors. Nevertheless, by 2005, after almost $50 billion of the products were sold, the NASD (now known as FINRA), decided to issue at least two Notices to Members (“NTM”) that warned brokerage firms that they should pay careful attention to whom they were marketing and selling such products. Notice to Members 05-26 states, in part:
In the current investment environment, investors and brokers are increasingly turning to alternatives to conventional equity and fixed-income investments in search of higher returns or yields. Such products, including … structured notes… are often complex or unique features that may not be fully understood by the retail customers to whom they are frequently offered, or even by the brokers who recommend them. Some appear to offer benefits to investors that are already available in the market in the form of less risky, less complicated, or less costly products, prompting concerns about suitability and potential conflicts of interest.